Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

about

Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3).Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.

P2860

Q42659391-A6C6B7A5-0635-44B4-8F52-069BBE18CDDD Q52689154-5CC4A2F7-1BF6-4AB5-9661-21D8D1135DC1

P2860

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

Item

http://www.wikidata.org/entity/Q36256343

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@ast

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@en

type

Item

label

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@ast

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@en

prefLabel

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@ast

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@en

P1476

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

@en

P2093

Aimee L Jalkanen

http://www.w3.org/2001/XMLSchema#string

Cheryl A London

http://www.w3.org/2001/XMLSchema#string

Ching-Shih Chen

http://www.w3.org/2001/XMLSchema#string

Samuel K Kulp

http://www.w3.org/2001/XMLSchema#string

Sridhar Murahari

http://www.w3.org/2001/XMLSchema#string

William C Kisseberth

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibitors: Potential in cancer therapy

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Dog models of naturally occurring cancer

The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.

Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.

The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin.

Toward a drug development path that targets metastatic progression in osteosarcoma.

P2888

s12885-017-3046-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3046-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaime Modiano

P577

2017-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053958578

http://www.w3.org/2001/XMLSchema#string

P698

28109246

http://www.w3.org/2001/XMLSchema#string

P932

5251323

http://www.w3.org/2001/XMLSchema#string

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

about

P2860

P2860

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932